欢迎来到天天文库
浏览记录
ID:54981614
大小:263.29 KB
页数:4页
时间:2020-05-07
《异甘草酸镁注射液治疗重症肝炎的疗效观察-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、现代药物与临床Drugs&Clinic第29卷第1期2014年1月·55·异甘草酸镁注射液治疗重症肝炎的疗效观察聂燕南京市第二医院肝病科,江苏南京210003摘要:目的观察异甘草酸镁注射液治疗重症肝炎的临床疗效。方法选取南京市第二医院2008年12月一2013年3月149例重症肝炎患者,随机分为治疗组(83例)和对照组(66例),治疗组给予异甘草酸镁注射液150mg加入5%~10%葡萄糖注射液中静脉滴注,1次/d;对照组给予复方甘草酸苷注射液160mg加入5%~10%葡萄糖注射液中静脉滴注,1次/d;治疗期间,两组还同时服用了保肝、抗病毒的药物,两组服用剂量和方法均相同,疗程均为4
2、周。治疗结束后检测两组患者肝功能、凝血功能等指标变化。结果与治疗前相比,两组患者治疗后的肝功能指标均有明显改善,治疗组丙氨酸氨基转移酶(ALT)、天门冬酸氨基转移酶(AST)明显低于对照组(P3、—0055.04DoI:1O.7501~.issn.1674-5515-2O14.01.013ClinicalobservationofMagnesiumIsoglycyrrhizinateInjectionontreatmentofserioushepatitisNIEYanDepartmentofHepatopathy,TheSecondHospitalofNanjing,Nanjing210003,ChinaAbstract:0bjectiveToobservetheclinicalefectsofMagnesiumIsoglycyrrhizinateInjection(MI4、I)onserioushepatitis.MethodsAtatalof149patientsofserioushepatitispatientsfromTheSecondHospitalofNanjingduringDecember,2008toMarch,2013wererandomlydividedintotreatmentandcontrolgroups.The83serioushepatitisSUferersweretreatedwith150mgMIIaddedinto250mL5%一l0%glucoseinjectionliquid.other66suferersa5、scontrolgroupweretreatedwith160mgCompoundGlycyrrhizinInjectionaddedinto250mL5%一10%glucoseinjectionliquid.ivdrippingoncedailyfor4weeks.Drugsforprotectingliver,antiviralweretakenwiththesamedosageandthemethodswerethesamefortwogroups.Whenthetreatmentwasover,thepracticalefectswereanalyzed.suchasliv6、erfunctionindexesandbloodcoagulationparameters.ResultsAftertreatment。theliverfunctionindexwassignificantlyimproved.Thelevelsofalanineaminotransferase(ALT)andaspartateaminotransferase(AST)intreatmentgroupweresignificantlylowerthanthoseinthecontrolgroup(尸<0.05).Therewasasignificantdecreaseoftota7、lbilirubin(TB)anddirectbilirubin(DB)intwogroupsaftertreatment(尸
3、—0055.04DoI:1O.7501~.issn.1674-5515-2O14.01.013ClinicalobservationofMagnesiumIsoglycyrrhizinateInjectionontreatmentofserioushepatitisNIEYanDepartmentofHepatopathy,TheSecondHospitalofNanjing,Nanjing210003,ChinaAbstract:0bjectiveToobservetheclinicalefectsofMagnesiumIsoglycyrrhizinateInjection(MI
4、I)onserioushepatitis.MethodsAtatalof149patientsofserioushepatitispatientsfromTheSecondHospitalofNanjingduringDecember,2008toMarch,2013wererandomlydividedintotreatmentandcontrolgroups.The83serioushepatitisSUferersweretreatedwith150mgMIIaddedinto250mL5%一l0%glucoseinjectionliquid.other66suferersa
5、scontrolgroupweretreatedwith160mgCompoundGlycyrrhizinInjectionaddedinto250mL5%一10%glucoseinjectionliquid.ivdrippingoncedailyfor4weeks.Drugsforprotectingliver,antiviralweretakenwiththesamedosageandthemethodswerethesamefortwogroups.Whenthetreatmentwasover,thepracticalefectswereanalyzed.suchasliv
6、erfunctionindexesandbloodcoagulationparameters.ResultsAftertreatment。theliverfunctionindexwassignificantlyimproved.Thelevelsofalanineaminotransferase(ALT)andaspartateaminotransferase(AST)intreatmentgroupweresignificantlylowerthanthoseinthecontrolgroup(尸<0.05).Therewasasignificantdecreaseoftota
7、lbilirubin(TB)anddirectbilirubin(DB)intwogroupsaftertreatment(尸
此文档下载收益归作者所有